We also confirmed by bioinformatic analysis [22] and luciferase reporter assay that miR-224 directly targeted RASSF8, a tumor suppressor [23–27], and played an oncogenic role in the progression of cervical cancer. Here, RASSF8 is linked to cervical cancer.